SCHEMBL27884309

SCHEMBL27884309

C=CC(c1ccc(C(C)C)cc1)S(=O)(=O)n1c(Cc2ccc(OC(N)=O)c(F)c2)cc2cc(Cl)ccc21

nearest known ligand 0.32

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 9/20 0.32
▸ PPARA Q07869 6/20 0.32
▸ PPARD Q03181 5/20 0.32
▸ CACNA1H O95180 4/20 0.32
▸ P2RX3 P56373 2/20 0.32
▸ ACLY P53396 2/20 0.31
▸ CACNA1G O43497 1/20 0.31
▸ CACNA1I Q9P0X4 1/20 0.31
▸ PSEN1 P49768 1/20 0.30
▸ PSEN2 P49810 1/20 0.30
▸ APH1B Q8WW43 1/20 0.30
▸ NCSTN Q92542 1/20 0.30
▸ APH1A Q96BI3 1/20 0.30
▸ PSENEN Q9NZ42 1/20 0.30
▸ PHGDH O43175 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27884205 0.86 PPARG (0.35) PPARGPPARAPPARDCACNA1HACLY
SCHEMBL27884308 0.83 PPARG (0.31) PPARGPPARAPPARDCACNA1HP2RX3
SCHEMBL27884222 0.81 PPARG (0.37) PPARGPPARAPPARDACLYPSEN1
SCHEMBL28797216 0.81 PHGDH (0.41) PPARGPPARAPPARDACLYPSEN1
SCHEMBL27867732 0.79 CCR2 (0.45) PPARGPPARAPPARDACLYPHGDH
SCHEMBL27884365 0.75 ACLY (0.40) PPARGPPARAPPARDACLYPHGDH
SCHEMBL27867735 0.75 ACLY (0.42) PPARGPPARAPPARDACLYPHGDH
SCHEMBL27884472 0.75 PHGDH (0.39) PPARGPPARAPPARDACLYPHGDH
SCHEMBL27713457 0.73 PSEN1 (0.46) ACLYPSEN1PSEN2APH1BNCSTN
SCHEMBL28800052 0.73 ACLY (0.43) PPARGPPARAPPARDACLYPHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596906-A Use of indole derivatives as NURR-1 activators as agents for the treatment of Parkinson's disease FOURNIER LAB SA 2012-07-18 — — CN disclosed
Send feedback